0001621221-26-000005.txt : 20260406 0001621221-26-000005.hdr.sgml : 20260406 20260406125738 ACCESSION NUMBER: 0001621221-26-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260406 DATE AS OF CHANGE: 20260406 EFFECTIVENESS DATE: 20260406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARTELO BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001621221 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 331220924 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-579170 FILM NUMBER: 26840290 BUSINESS ADDRESS: STREET 1: 505 LOMAS SANTA FE, SUITE 160 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-925-7049 MAIL ADDRESS: STREET 1: 505 LOMAS SANTA FE, SUITE 160 CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER COMPANY: FORMER CONFORMED NAME: REACTIVE MEDICAL INC. DATE OF NAME CHANGE: 20170207 FORMER COMPANY: FORMER CONFORMED NAME: KNIGHT KNOX DEVELOPMENT CORP. DATE OF NAME CHANGE: 20141001 D 1 primary_doc.xml X0708 D LIVE 0001621221 ARTELO BIOSCIENCES, INC. 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA CALIFORNIA 92075 858-925-7049 NEVADA REACTIVE MEDICAL INC. KNIGHT KNOX DEVELOPMENT CORP. Corporation true Gregory D. Gorgas c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CA CALIFORNIA 92075 Executive Officer Director Connie Matsui c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CA CALIFORNIA 92075 Director Douglas Blayney c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CA CALIFORNIA 92075 Director Steven Kelly c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CA CALIFORNIA 92075 Director R. Martin Emanuele c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CA CALIFORNIA 92075 Director Tamara A. Favorito c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CA CALIFORNIA 92075 Director Gregory R. Reyes c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CA CALIFORNIA 92075 Director Mark Spring c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CA CALIFORNIA 92075 Executive Officer Biotechnology Decline to Disclose 06b false 2026-03-27 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 4TH FLOOR NEW YORK NY NEW YORK 10022 All States false 10996903 10996903 0 false 2 880000 0 Commission is 8% of gross amount received at closing and upon cash exercise of investor warrants with an expense allowance of up to $85,000 and 5.5-year warrants to acquire 255,073 shares of common stock at an exercise price of $4.3125 per share. 575450 false ARTELO BIOSCIENCES, INC. Gregory D. Gorgas Gregory D. Gorgas President & CEO 2026-04-06